IV, K., I, N., P, R., P, M., C, P., E, E., . . . E, T. (2024). Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma. American journal of hematology, 99(10), 1887. https://doi.org/10.1002/ajh.27414
Chicago Style (17th ed.) CitationIV, Kostopoulos, et al. "Low Circulating Tumor Cell Levels Correlate with Favorable Outcomes and Distinct Biological Features in Multiple Myeloma." American Journal of Hematology 99, no. 10 (2024): 1887. https://doi.org/10.1002/ajh.27414.
MLA (9th ed.) CitationIV, Kostopoulos, et al. "Low Circulating Tumor Cell Levels Correlate with Favorable Outcomes and Distinct Biological Features in Multiple Myeloma." American Journal of Hematology, vol. 99, no. 10, 2024, p. 1887, https://doi.org/10.1002/ajh.27414.